Consumer Durables News

Dow reports second quarter 2022 results

[ad_1]

MIDLAND, Mich., July 21, 2022 /PRNewswire/ — Dow (NYSE: DOW)

FINANCIAL HIGHLIGHTS

  • GAAP earnings per share (EPS) was $2.26; Operating EPS1 was $2.31, compared to $2.72 in the year-ago period and $2.34 in the prior quarter. Operating EPS excludes significant items in the quarter, totaling $0.05 per share, primarily related to digitalization program costs.
  • Net sales were $15.7 billion, up 13% versus the year-ago period with gains in all operating segments and regions. Sequentially, sales were up 3% with gains in all regions except Asia Pacific, which was impacted by pandemic-related lockdowns in China.
  • Local price increased 16% versus the year-ago period, reflecting gains in all operating segments, businesses, and regions. Currency decreased net sales by 3% year-over-year due to broad-based strength of the U.S. dollar. Sequentially, local price increased 6% with gains in all operating segments and regions.
  • Volume was consistent with the year-ago period, as gains in Packaging & Specialty Plastics were primarily offset by declines in Industrial Intermediates & Infrastructure. Sequentially, volume declined 2%, driven by declines primarily in Europe and China.
  • Equity earnings were $195 million, down $83 million from the year-ago period, primarily due to impacts from pandemic-related lockdowns in China. Equity earnings were up $21 million from the prior quarter, driven by gains at Sadara.
  • GAAP Net Income was $1.7 billion. Operating EBIT1 was $2.4 billion, down $453 million versus the year-ago period. Gains in the Performance Materials & Coatings segment were more than offset by higher raw material and energy costs across the company as well as lower equity earnings. Sequentially, operating EBIT decreased 2%, as gains in Packaging & Specialty Plastics were more than offset by declines in Industrial Intermediates & Infrastructure.
  • Cash provided by operating activities – continuing operations was $1.9 billion, down $165 million year-over-year and up $244 million compared to the prior quarter. Free cash flow1 was $1.4 billion.
  • The Company’s proactive actions to redeem outstanding notes totaling $750 million have delivered an annual interest expense reduction of $27 million and no substantive long-term debt maturities are due until 2027.
  • Returns to shareholders totaled $1.3 billion in the quarter, comprised of $800 million in share repurchases and $505 million in dividends.

SUMMARY FINANCIAL RESULTS


Three Months Ended June 30

Three Months Ended March 31

In millions, except per share amounts

2Q22

2Q21

vs. SQLY

[B / (W)]

1Q22

vs. PQ

[B / (W)]

Net Sales

$15,664

$13,885

$1,779

$15,264

$400

GAAP Income, Net of Tax

$1,681

$1,932

$(251)

$1,552

$129

Operating EBIT¹

$2,375

$2,828

$(453)

$2,419

$(44)

Operating EBIT Margin¹

15.2 %

20.4 %

(520) bps  

15.9 %

(70) bps  

Operating EBITDA¹

$3,059

$3,573

$(514)

$3,171

$(112)

GAAP Earnings Per Share

$2.26

$2.51

$(0.25)

$2.11

$0.15

Operating Earnings Per Share¹

$2.31

$2.72

$(0.41)

$2.34

$(0.03)

Cash Provided by Operating
Activities – Cont. Ops

$1,856

$2,021

$(165)

$1,612

$244

  1. Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin, Op. EBITDA, and Free Cash Flow are non-GAAP measures. See page 6 for further discussion.
    ®TM Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow 

CEO QUOTE

Jim Fitterling, chairman and chief executive officer, commented on the quarter:

“Team Dow once again delivered net sales growth both year-over-year and sequentially with price increases across all operating segments and regions. Our competitive advantages and relentless focus on disciplined execution enabled us to navigate the impacts of pandemic-related lockdowns in China, continued logistics constraints, and higher energy and raw material costs. As a result, we increased our cash flow and our share buybacks sequentially.

“We continued to progress our strategy to grow our underlying earnings over the economic cycle by investing in higher-return, faster-payback projects while capitalizing on long-term growth opportunities. As part of these efforts, today we announced a series of circularity projects that will enable us to achieve approximately two thirds of our 2030 ‘Stop the Waste’ target as we capture growth for the sustainable and circular solutions our customers are increasingly demanding.”

SEGMENT HIGHLIGHTS

Packaging & Specialty Plastics


Three Months Ended June 30

Three Months Ended March 31

In millions, except margin percentages

2Q22

2Q21

vs. SQLY

[B / (W)]

1Q22

vs. PQ

[B / (W)]

Net Sales

$8,233

$7,121

$1,112

$7,627

$606

Operating EBIT

$1,436

$2,014

($578)

$1,234

$202

Operating EBIT Margin

17.4 %

28.3 %

(1090) bps  

16.2 %

120 bps   

Equity Earnings

$138

$130

$8

$110

$28

Packaging & Specialty Plastics segment net sales in the quarter were $8.2 billion, up 16% versus the year-ago period. Local price increased 14% year-over-year due to tight supply and demand balances, with gains in both businesses and in all regions. Continued strong end-market demand drove a 5% year-over-year volume increase, with gains in energy, infrastructure, and packaging applications. Currency decreased net sales by 3%. On a sequential basis, the segment delivered an 8% net sales increase, driven primarily by local price gains in both businesses and in all regions.

Equity earnings were $138 million, up $8 million compared to the year-ago period primarily due to the Sadara joint venture. On a sequential basis, equity earnings increased by $28 million on gains at Sadara and the Kuwait joint ventures.

Operating EBIT was $1.4 billion, compared to $2 billion in the year-ago period, as price increases were more than offset by rapidly rising raw material and energy costs. Sequentially, Op. EBIT was up $202 million and Op. EBIT margins increased by 120 basis points due to improved product mix and integrated margins which offset higher raw material and energy costs, primarily in the U.S. & Canada.

Packaging and Specialty Plastics business delivered a net sales increase versus the year-ago period due to both local price and volume gains. Prices increased across all key product chains, led by gains in functional polymers and volumes increased on strong demand growth in packaging end-markets and materials for renewable energy applications. Sequentially, the business increased revenue on price gains in all regions, primarily in industrial, consumer, and food packaging applications.

Hydrocarbons & Energy business delivered a net sales increase compared to the year-ago period, driven primarily by higher local prices for olefins and aromatics. Sequentially, sales increased due to higher olefin prices with gains in Europe and the U.S. & Canada.

Industrial Intermediates & Infrastructure


Three Months Ended June 30

Three Months Ended March 31

In millions, except margin percentages

2Q22

2Q21

vs. SQLY

[B / (W)]

1Q22

vs. PQ

[B / (W)]

Net Sales

$4,370

$4,215

$155

$4,524

$(154)

Operating EBIT

$426

$648

$(222)

$661

$(235)

Operating EBIT Margin

9.7 %

15.4 %

(570) bps  

14.6 %

(490) bps  

Equity Earnings

$57

$144

$(87)

$62

$(5)

Industrial Intermediates & Infrastructure segment net sales were $4.4 billion, up 4% versus the year-ago period. Local price improved 14% year-over-year with gains in both businesses. Currency decreased net sales by 4%. Volume was down 6% year-over-year, as declines in Polyurethanes & Construction Chemicals were partly offset by gains in Industrial Solutions. On a sequential basis, the segment recorded a net sales decline of 3%, as lower volumes due to planned maintenance turnaround activity and third-party outages were partly offset by price gains in both businesses.

Equity earnings for the segment were $57 million, a decrease of $87 million compared to the year-ago period, driven by the impact of pandemic-related lockdowns in China. On a sequential basis, equity earnings decreased by $5 million due to lower MEG margins at the Kuwait joint ventures.

Operating EBIT was $426 million, compared to $648 million in the year-ago period and $661 million in the prior quarter, as increased planned maintenance turnaround activity along with raw material and energy costs were partly offset by higher pricing.

Polyurethanes & Construction Chemicals business net sales decreased compared to the year-ago period, as local price gains were more than offset by local currency and lower volume due to planned maintenance turnaround activity, third-party outages, and inflationary impacts on demand for consumer durables. Sequentially, net sales declined as lower volumes from planned maintenance turnaround activity and third-party outages were partly offset by higher local price.

Industrial Solutions business delivered a net sales increase compared to the year-ago period, with local price and volume gains in all regions. Volume increased year-over-year on higher supply availability and strong demand for pharmaceutical, agricultural, and oil & gas-related applications. Net sales declined sequentially as lower seasonal demand for deicing fluids was partly offset by local price gains in all regions.

Performance Materials & Coatings


Three Months Ended June 30

Three Months Ended March 31

In millions, except margin
percentages

2Q22

2Q21

vs. SQLY

[B / (W)]

1Q22

vs. PQ

[B / (W)]

Net Sales

$3,003

$2,465

$538

$3,049

$(46)

Operating EBIT

$561

$225

$336

$595

$(34)

Operating EBIT Margin

18.7 %

9.1 %

960 bps   

19.5 %

(80) bps  

Equity Earnings

$2

$2

$3

$(1)

Performance Materials & Coatings segment net sales in the quarter were $3 billion, up 22% versus the year-ago period. Local price increased 28% year-over-year, with gains in both businesses and all regions. Currency decreased net sales by 3%. Volume declined 3% year-over-year, primarily due to the impact of pandemic-related lockdowns in China, which were partly offset by stronger demand for silicones and coatings applications in the U.S. & Canada. On a sequential basis, net sales were down 2%, as local currency impacts and lower volume in Europe and China were partly offset by strong consumer demand in the U.S. & Canada as well as higher seasonal demand for coatings applications.

Operating EBIT was $561 million, compared to $225 million in the year-ago period, as Op. EBIT margins expanded by 960 basis points primarily due to pricing gains for both silicones and coatings applications. Sequentially, Op. EBIT declined $34 million as lower siloxane prices in Europe and China were partly offset by margin expansion in Coatings & Performance Monomers.

Consumer Solutions business delivered higher net sales versus the year-ago period, with local price gains in all regions and end-market applications. Volume declined year-over-year as strong consumer demand in the U.S. & Canada was more than offset by the impact of pandemic-related lockdowns in China. Sequentially, net sales declined as volume gains from strong demand for building and construction, infrastructure, and mobility end markets were more than offset by lower siloxane volumes and prices in Europe and China.

Coatings & Performance Monomers business delivered increased net sales compared to the year-ago period, with local price gains in all regions. Despite increased supply availability in the U.S. & Canada, volume overall declined year-over-year primarily due to pandemic-related lockdowns in China. Sequentially, net sales increased with local price gains in all regions and increased volumes driven by strong seasonal demand in the U.S. & Canada.

OUTLOOK

“Looking ahead, the long-term fundamentals driving growth across our end markets remain attractive,” said Fitterling. “While near-term market conditions are dynamic, we will continue to leverage our diverse, global portfolio and flexible operating model to capitalize on attractive growth opportunities. The actions we’ve taken to enhance the resiliency of our business position us well to deliver value across a variety of economic environments. Our disciplined and balanced approach to capital allocation has delivered higher mid-cycle earnings, an improved credit profile, and cash generation above pre-pandemic levels. Team Dow remains well-positioned to continue advancing our “decarbonize and grow” strategy while delivering attractive shareholder remuneration.”

Conference Call

Dow will host a live webcast of its second quarter earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.

About Dow

Dow (NYSE: DOW) combines global breadth; asset integration and scale; focused innovation and materials science expertise; leading business positions; and environmental, social and governance (ESG) leadership to achieve profitable growth and deliver a sustainable future. The Company’s ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company in the world. Dow’s portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated, science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility and consumer applications. Dow operates 104 manufacturing sites in 31 countries and employs approximately 35,700 people. Dow delivered sales of approximately $55 billion in 2021. References to Dow or the Company mean Dow Inc. and its subsidiaries. For more information, please visit www.dow.com or follow @DowNewsroom on Twitter.

Cautionary Statement about Forward-Looking Statements

Certain statements in this report are “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases.

Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow’s control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow’s products; Dow’s expenses, future revenues and profitability; the continuing global and regional economic impacts of the coronavirus disease 2019 (“COVID-19”) pandemic and other public health-related risks and events on Dow’s business; any sanction, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflict between Russia and Ukraine; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow’s contemplated capital and operating projects; Dow’s ability to realize its commitment to carbon neutrality on the contemplated timeframe; size of the markets for Dow’s products and services and ability to compete in such markets; failure to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow’s products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow’s intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow’s significant customers and suppliers; changes in consumer preferences and demand; changes in laws and regulations, political conditions or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war including the ongoing conflict between Russia and Ukraine; weather events and natural disasters; disruptions in Dow’s information technology networks and systems; and risks related to Dow’s separation from DowDuPont Inc. such as Dow’s obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow’s business. Dow and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

®TM Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow

Non-GAAP Financial Measures

This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company’s segments, including allocating resources. Dow’s management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company’s U.S. GAAP disclosures and should not be viewed as alternatives to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.

Operating Earnings Per Share is defined as “Earnings per common share – diluted” excluding the after-tax impact of significant items.

Operating EBIT is defined as earnings (i.e., “Income before income taxes”) before interest, excluding the impact of significant items.

Operating EBIT margin is defined as Operating EBIT as a percentage of net sales.

Operating EBITDA is defined as earnings (i.e., “Income before income taxes”) before interest, depreciation and amortization, excluding the impact of significant items.

Free Cash Flow is defined as “Cash provided by operating activities – continuing operations,” less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company’s financial planning process.

Cash Flow Conversion is defined as “Cash provided by operating activities – continuing operations,” divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

Operating Return on Capital (ROC) is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.

Dow Inc. and Subsidiaries

Consolidated Statements of Income

In millions, except per share amounts (Unaudited)

Three Months Ended 

Six Months Ended

Jun 30,
2022

Jun 30,
2021

Jun 30,
2022

Jun 30,
2021

Net sales

$   15,664

$   13,885

$   30,928

$   25,767

Cost of sales

12,899

10,740

25,301

20,802

Research and development expenses

217

228

435

422

Selling, general and administrative expenses

435

440

933

806

Amortization of intangibles

85

100

173

201

Restructuring and asset related charges – net

22

186

22

Equity in earnings of nonconsolidated affiliates

195

278

369

502

Sundry income (expense) – net

75

(3)

223

125

Interest income

36

13

64

21

Interest expense and amortization of debt discount

165

187

332

383

Income before income taxes

2,169

2,456

4,224

3,779

Provision for income taxes

488

524

991

841

Net income

1,681

1,932

3,233

2,938

Net income attributable to noncontrolling interests

20

31

3

46

Net income available for Dow Inc. common stockholders

$    1,661

$    1,901

$    3,230

$    2,892






Per common share data:





Earnings per common share – basic

$      2.28

$      2.53

$      4.40

$      3.86

Earnings per common share – diluted

$      2.26

$      2.51

$      4.37

$      3.83






Weighted-average common shares outstanding – basic

725.7

747.0

730.2

745.9

Weighted-average common shares outstanding – diluted

731.5

752.9

735.6

751.4

Dow Inc. and Subsidiaries
Consolidated Balance Sheets

In millions, except share amounts (Unaudited)

Jun 30,
2022

Dec 31,
2021

Assets



Current Assets



Cash and cash equivalents

$         2,367

$         2,988

Accounts and notes receivable:



Trade (net of allowance for doubtful receivables – 2022: $212; 2021: $54)

7,474

6,841

Other

2,243

2,713

Inventories

8,225

7,372

Other current assets

1,460

934

Total current assets

21,769

20,848

Investments



Investment in nonconsolidated affiliates

1,862

2,045

Other investments (investments carried at fair value – 2022: $1,753; 2021: $2,079)

2,782

3,193

Noncurrent receivables

537

478

Total investments

5,181

5,716

Property



Property

57,180

57,604

Less: Accumulated depreciation

37,020

37,049

Net property

20,160

20,555

Other Assets



Goodwill

8,605

8,764

Other intangible assets (net of accumulated amortization – 2022: $4,833; 2021: $4,725)

2,616

2,881

Operating lease right-of-use assets

1,272

1,412

Deferred income tax assets

1,118

1,358

Deferred charges and other assets

1,422

1,456

Total other assets

15,033

15,871

Total Assets

$       62,143

$       62,990

Liabilities and Equity



Current Liabilities



Notes payable

$           295

$           161

Long-term debt due within one year

361

231

Accounts payable:



Trade

5,693

5,577

Other

2,824

2,839

Operating lease liabilities – current

290

314

Income taxes payable

462

623

Accrued and other current liabilities

3,384

3,481

Total current liabilities

13,309

13,226

Long-Term Debt

13,065

14,280

Other Noncurrent Liabilities



Deferred income tax liabilities

752

506

Pension and other postretirement benefits – noncurrent

6,934

7,557

Asbestos-related liabilities – noncurrent

887

931

Operating lease liabilities – noncurrent

1,043

1,149

Other noncurrent obligations

6,646

6,602

Total other noncurrent liabilities

16,262

16,745

Stockholders’ Equity



Common stock (authorized 5,000,000,000 shares of $0.01 par value each;

issued 2022: 768,558,885 shares; 2021: 764,226,882 shares)

8

8

Additional paid-in capital

8,343

8,151

Retained earnings

22,827

20,623

Accumulated other comprehensive loss

(9,204)

(8,977)

Unearned ESOP shares

(15)

Treasury stock at cost (2022: 50,391,408 shares; 2021: 29,011,573 shares)

(3,001)

(1,625)

Dow Inc.’s stockholders’ equity

18,973

18,165

Noncontrolling interests

534

574

Total equity

19,507

18,739

Total Liabilities and Equity

$       62,143

$       62,990

Dow Inc. and Subsidiaries
Consolidated Statements of Cash Flows

In millions (Unaudited)

Six Months Ended

Jun 30,
2022

Jun 30,
2021

Operating Activities



Net income

$       3,233

$       2,938

Adjustments to reconcile net income to net cash provided by operating activities:



Depreciation and amortization

1,436

1,462

Provision for deferred income tax

348

388

Earnings of nonconsolidated affiliates less than (in excess of) dividends received

289

(283)

Net periodic pension benefit cost

14

29

Pension contributions

(89)

(1,109)

Net (gain) loss on sales of assets, businesses and investments

6

(50)

Restructuring and asset related charges – net

186

22

Other net loss

92

224

Changes in assets and liabilities, net of effects of acquired and divested companies:



Accounts and notes receivable

(767)

(1,903)

Inventories

(908)

(1,278)

Accounts payable

69

1,357

Other assets and liabilities, net

(441)

(4)

Cash provided by operating activities – continuing operations

3,468

1,793

Cash used for operating activities – discontinued operations

(11)

(80)

Cash provided by operating activities

3,457

1,713

Investing Activities



Capital expenditures

(772)

(622)

Investment in gas field developments

(80)

(24)

Purchases of previously leased assets

(3)

(3)

Proceeds from sales of property and businesses, net of cash divested

5

10

Acquisitions of property and businesses, net of cash acquired

(107)

Investments in and loans to nonconsolidated affiliates

(33)

Distributions and loan repayments from nonconsolidated affiliates

10

11

Proceeds from sales of ownership interests in nonconsolidated affiliates

11

Purchases of investments

(278)

(560)

Proceeds from sales and maturities of investments

418

527

Other investing activities, net

(41)

Cash used for investing activities

(763)

(768)

Financing Activities



Changes in short-term notes payable

180

(38)

Proceeds from issuance of short-term debt greater than three months

72

Payments on short-term debt greater than three months

(14)

Proceeds from issuance of long-term debt

49

68

Payments on long-term debt

(927)

(1,425)

Purchases of treasury stock

(1,400)

(200)

Proceeds from issuance of stock

97

200

Transaction financing, debt issuance and other costs

(7)

(95)

Employee taxes paid for share-based payment arrangements

(34)

(11)

Distributions to noncontrolling interests

(22)

(28)

Dividends paid to stockholders

(1,018)

(1,043)

Cash used for financing activities

(3,096)

(2,500)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(162)

(12)

Summary



Decrease in cash, cash equivalents and restricted cash

(564)

(1,567)

Cash, cash equivalents and restricted cash at beginning of period

3,033

5,108

Cash, cash equivalents and restricted cash at end of period

$       2,469

$       3,541

Less: Restricted cash and cash equivalents, included in “Other current assets”

102

50

Cash and cash equivalents at end of period

$       2,367

$       3,491

Dow Inc. and Subsidiaries

Net Sales by Segment and Geographic Region

Net Sales by Segment

Three Months Ended 

Six Months Ended

In millions (Unaudited)

Jun 30,
2022

Jun 30,
2021

Jun 30,
2022

Jun 30,
2021

Packaging & Specialty Plastics

$    8,233

$    7,121

$   15,860

$   13,203

Industrial Intermediates & Infrastructure

4,370

4,215

8,894

7,822

Performance Materials & Coatings

3,003

2,465

6,052

4,588

Corporate

58

84

122

154

Total

$   15,664

$   13,885

$   30,928

$   25,767

U.S. & Canada

$    5,707

$    4,927

$   11,244

$    8,955

EMEAI 1

5,677

5,102

11,189

9,431

Asia Pacific

2,673

2,479

5,426

4,844

Latin America

1,607

1,377

3,069

2,537

Total

$   15,664

$   13,885

$   30,928

$   25,767

Net Sales Variance by
Segment and
Geographic Region

Three Months Ended Jun 30, 2022

Six Months Ended Jun 30, 2022


Local
Price &
Product
Mix

Currency 

Volume 

Total 

Local
Price &
Product
Mix

Currency 

Volume 

Total 


Percent change from prior year


Packaging & Specialty
  Plastics

14 %

(3) %

5 %

16 %

20 %

(3) %

3 %

20 %


Industrial Intermediates
  & Infrastructure

14

(4)

(6)

4

21

(4)

(3)

14


Performance Materials &
  Coatings

28

(3)

(3)

22

34

(3)

1

32


Total

16 %

(3) %

— %

13 %

22 %

(3) %

1 %

20 %


Total, excluding the
  Hydrocarbons & Energy
  business

14 %

(4) %

(2) %

8 %

21 %

(3) %

(1) %

17 %


U.S. & Canada

13 %

— %

3 %

16 %

19 %

— %

7 %

26 %


EMEAI 1

24

(9)

(4)

11

31

(8)

(4)

19


Asia Pacific

11

(3)

8

16

(2)

(2)

12


Latin America

8

1

8

17

16

5

21


Total

16 %

(3) %

— %

13 %

22 %

(3) %

1 %

20 %


Net Sales Variance by Segment and Geographic Region

Three Months Ended Jun 30, 2022


Local
Price &
Product
Mix

Currency 

Volume 

Total 


Percent change from prior quarter


Packaging & Specialty Plastics

9 %

(1) %

— %

8 %


Industrial Intermediates & Infrastructure

3

(1)

(5)

(3)


Performance Materials & Coatings

1

(2)

(1)

(2)


Total

6 %

(1) %

(2) %

3 %


Total, excluding the Hydrocarbons & Energy business

4 %

(1) %

(3) %

— %


U.S. & Canada

4 %

— %

(1) %

3 %


EMEAI 1

9

(3)

(3)

3


Asia Pacific

2

(2)

(3)

(3)


Latin America

8

2

10


Total

6 %

(1) %

(2) %

3 %


  1. Europe, Middle East, Africa and India.

Dow Inc. and Subsidiaries
Selected Financial Information and Non-GAAP Measures

Operating EBIT by Segment


Three Months Ended

Six Months Ended

In millions (Unaudited)


Jun 30,
2022

Jun 30,
2021

Jun 30,
2022

Jun 30,
2021

Packaging & Specialty Plastics


$    1,436

$    2,014

$    2,670

$    3,242

Industrial Intermediates & Infrastructure


426

648

1,087

974

Performance Materials & Coatings


561

225

1,156

287

Corporate


(48)

(59)

(119)

(121)

Total


$    2,375

$    2,828

$    4,794

$    4,382







Depreciation and Amortization by Segment


Three Months Ended

Six Months Ended

In millions (Unaudited)


Jun 30,
2022

Jun 30,
2021

Jun 30,
2022

Jun 30,
2021

Packaging & Specialty Plastics


$       344

$       352

$       739

$       688

Industrial Intermediates & Infrastructure


136

168

286

324

Performance Materials & Coatings


197

217

397

435

Corporate


7

8

14

15

Total


$       684

$       745

$    1,436

$    1,462







Operating EBITDA by Segment


Three Months Ended

Six Months Ended

In millions (Unaudited)


Jun 30,
2022

Jun 30,
2021

Jun 30,
2022

Jun 30,
2021

Packaging & Specialty Plastics


$    1,780

$    2,366

$    3,409

$    3,930

Industrial Intermediates & Infrastructure


562

816

1,373

1,298

Performance Materials & Coatings


758

442

1,553

722

Corporate


(41)

(51)

(105)

(106)

Total


$    3,059

$    3,573

$    6,230

$    5,844







Equity in Earnings (Losses) of Nonconsolidated Affiliates by Segment


Three Months Ended

Six Months Ended

In millions (Unaudited)


Jun 30,
2022

Jun 30,
2021

Jun 30,
2022

Jun 30,
2021

Packaging & Specialty Plastics


$       138

$       130

$       248

$       236

Industrial Intermediates & Infrastructure


57

144

119

259

Performance Materials & Coatings


2

5

2

Corporate


(2)

4

(3)

5

Total


$       195

$       278

$       369

$       502







Reconciliation of “Net income” to “Operating EBIT”

Three Months Ended

Six Months Ended

In millions (Unaudited)

Mar 31,
2022

Jun 30,
2022

Jun 30,
2021

Jun 30,
2022

Jun 30,
2021

Net income

$    1,552

$    1,681

$    1,932

$    3,233

$    2,938

+ Provision for income taxes

503

488

524

991

841

Income before income taxes

$    2,055

$    2,169

$    2,456

$    4,224

$    3,779

–  Interest income

28

36

13

64

21

+ Interest expense and amortization of debt discount

167

165

187

332

383

–  Significant items

(225)

(77)

(198)

(302)

(241)

Operating EBIT (non-GAAP)

$    2,419

$    2,375

$    2,828

$    4,794

$    4,382

   

Dow Inc. and Subsidiaries
Selected Financial Information and Non-GAAP Measures

Significant Items Impacting Results for the Three Months Ended Jun 30, 2022

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   2,169

$   1,661

$     2.26


Less: Significant items





Digitalization program costs 4

(51)

(40)

(0.05)

Cost of sales ($44 million);

 R&D ($1 million); SG&A ($6 million)

Restructuring, implementation costs and
  asset related charges – net 5

(10)

(8)

(0.01)

Cost of sales ($8 million);

 R&D ($2 million)

Loss on early extinguishment of debt

(8)

(6)

(0.01)

Sundry income (expense) – net

Indemnification and other transaction
  related costs 6

(8)

(8)

(0.01)

Sundry income (expense) – net

Income tax related items

25

0.03

Provision for income taxes on
  continuing operations

Total significant items

$      (77)

$      (37)

$   (0.05)


Operating results (non-GAAP)

$   2,246

$   1,698

$     2.31


   

Significant Items Impacting Results for the Three Months Ended Jun 30, 2021

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   2,456

$   1,901

$     2.51


Less: Significant items





Digitalization program costs 4

(48)

(37)

(0.05)

Cost of sales ($41 million);

 R&D ($1 million); SG&A ($6 million)

Restructuring, implementation costs and
  asset related charges – net 5

(43)

(34)

(0.04)

Cost of sales ($17 million);

 R&D ($2 million); SG&A ($2 million);
 Restructuring and asset related
 charges – net ($22 million)

Loss on early extinguishment of debt

(102)

(84)

(0.11)

Sundry income (expense) – net

Indemnification and other transaction
  related costs 6

(5)

(5)

(0.01)

Sundry income (expense) – net

Total significant items

$    (198)

$    (160)

$   (0.21)


Operating results (non-GAAP)

$   2,654

$   2,061

$     2.72


  1. “Income before income taxes.”
  2. “Net income available for Dow Inc. common stockholders.” The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  3. “Earnings per common share – diluted,” which includes the impact of participating securities in accordance with the two-class method.
  4. Costs associated with implementing the Company’s Digital Acceleration program.
  5. Restructuring charges, asset related charges and costs associated with implementing the Company’s 2020 Restructuring Program.
  6. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

Dow Inc. and Subsidiaries
Selected Financial Information and Non-GAAP Measures

Significant Items Impacting Results for the Six Months Ended Jun 30, 2022

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   4,224

$   3,230

$     4.37


Less: Significant items





Digitalization program costs 4

(92)

(72)

(0.09)

Cost of sales ($82 million);

 R&D ($2 million); SG&A ($8 million)

Restructuring, implementation costs and
  asset related charges – net 5

(20)

(16)

(0.02)

Cost of sales ($15 million);

 R&D ($4 million); SG&A ($1 million)

Russia / Ukraine conflict charges 6

(186)

(142)

(0.19)

Restructuring and asset related charges
  – net

Loss on early extinguishment of debt

(8)

(6)

(0.01)

Sundry income (expense) – net

Indemnification and other transaction
  related costs 7

4

4

Sundry income (expense) – net

Income tax related items

25

0.03

Provision for income taxes on
  continuing operations

Total significant items

$    (302)

$    (207)

$   (0.28)


Operating results (non-GAAP)

$   4,526

$   3,437

$     4.65


Significant Items Impacting Results for the Six Months Ended Jun 30, 2021

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   3,779

$   2,892

$     3.83


Less: Significant items





Digitalization program costs 4

(81)

(62)

(0.08)

Cost of sales ($70 million);

 R&D ($1 million); SG&A ($10 million)

Restructuring, implementation costs and
  asset related charges – net 5

(53)

(42)

(0.05)

Cost of sales ($26 million);

 R&D ($3 million); SG&A ($2 million);
 Restructuring and asset related
 charges – net ($22 million)

Loss on early extinguishment of debt

(102)

(84)

(0.11)

Sundry income (expense) – net

Indemnification and other transaction
  related costs 7

(5)

(5)

(0.01)

Sundry income (expense) – net

Total significant items

$    (241)

$    (193)

$   (0.25)


Operating results (non-GAAP)

$   4,020

$   3,085

$     4.08


  1. “Income before income taxes”
  2. “Net income (loss) available for Dow Inc. common stockholders.” The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  3. “Earnings per common share – diluted,” which includes the impact of participating securities in accordance with the two-class method.
  4. Costs associated with implementing the Company’s Digital Acceleration program.
  5. Restructuring charges, asset related charges and costs associated with implementing the Company’s 2020 Restructuring Program.
  6. Asset related charges including inventory write-downs, bad debt reserves and impairments of other assets related to the conflict between Russia and Ukraine.
  7. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

Dow Inc. and Subsidiaries
Selected Financial Information and Non-GAAP Measures

Significant Items Impacting Results for the Three Months Ended Mar 31, 2022

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   2,055

$   1,569

$     2.11


Less: Significant items





Digitalization program costs 4

(41)

(32)

(0.04)

Cost of sales ($38 million);

 R&D ($1 million); SG&A ($2 million)

Restructuring, implementation costs and
  asset related charges – net 5

(10)

(8)

(0.01)

Cost of sales ($7 million);

 R&D ($2 million); SG&A ($1 million)

Russia / Ukraine conflict charges 6

(186)

(142)

(0.19)

Restructuring and asset related charges
  – net

Indemnification and other transaction
  related costs 7

12

12

0.01

Sundry income (expense) – net

Total significant items

$    (225)

$    (170)

$   (0.23)


Operating results (non-GAAP)

$   2,280

$   1,739

$     2.34


  1. “Income before income taxes”
  2. “Net income available for Dow Inc. common stockholders.” The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
  3. “Earnings per common share – diluted,” which includes the impact of participating securities in accordance with the two-class method.
  4. Costs associated with implementing the Company’s Digital Acceleration program.
  5. Costs associated with implementing the Company’s 2020 Restructuring Program.
  6. Asset related charges including inventory write-downs, bad debt reserves and impairments of other assets related to the conflict between Russia and Ukraine.
  7. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

Reconciliation of Free Cash Flow

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30,
2022

Jun 30,
2021

Jun 30,
2022

Jun 30,
2021

Cash provided by operating activities – continuing operations (GAAP)

$    1,856

$    2,021

$    3,468

$    1,793

Capital expenditures

(457)

(333)

(772)

(622)

Free Cash Flow (non-GAAP) 1

$    1,399

$    1,688

$    2,696

$    1,171

  1. Free cash flow in the first six months of 2021 reflects a $1 billion elective pension contribution.

Reconciliation of Cash Flow Conversion

Three Months Ended

In millions (Unaudited)

Sep 30,
2021

Dec 31,
2021

Mar 31,
2022

Jun 30,
2022

Cash provided by operating activities – continuing operations (GAAP)

$ 2,719

$ 2,557

$ 1,612

$ 1,856

Operating EBITDA (non-GAAP)

$ 3,611

$ 2,920

$ 3,171

$ 3,059

Cash Flow Conversion (Operating EBITDA to cash flow from
  operations) (non-GAAP)

75.3 %

87.6 %

50.8 %

60.7 %

Cash Flow Conversion – trailing twelve months (non-GAAP)


68.5 %

Twitter: https://twitter.com/DowNewsroom 
Facebook: https://www.facebook.com/dow/ 
LinkedIn: http://www.linkedin.com/company/dow-chemical 
Instagram: http://instagram.com/dow_official 

SOURCE The Dow Chemical Company



[ad_2]

Source link